Baerbel LoSacco

Title: Baerbel LoSacco: Innovator in CD38 Splice Variants

Introduction

Baerbel LoSacco is a notable inventor based in New Milford, CT (US). She has made significant contributions to the field of biotechnology, particularly in the area of CD38 splice variants. Her work has implications for treating and diagnosing various disorders.

Latest Patents

Baerbel LoSacco holds a patent for "CD38 splice variants and uses thereof." This invention provides a substantially purified polypeptide known as CD38JL, which is a CD38 splice variant comprised of the polypeptide of SEQ ID NO: 1 or a fragment thereof. The invention also outlines methods for treating, preventing, and diagnosing disorders associated with the expression of CD38JL. She has 1 patent to her name.

Career Highlights

Baerbel LoSacco is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc. Her role at the company allows her to further her research and development efforts in the biotechnology sector.

Collaborations

Throughout her career, Baerbel has collaborated with esteemed colleagues, including Jun Li and Xiang Li. These partnerships have contributed to her innovative work and advancements in her field.

Conclusion

Baerbel LoSacco's contributions to the field of biotechnology, particularly through her patent on CD38 splice variants, highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical treatments and diagnostics.